Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Prostate Cancer

Free Subscription Articles published in AJR Am J Roentgenol Retrieve available abstracts of 34 articles: HTML format

Single Articles

August 2026
1. DOMONKOS V, Doherty A, Smyth V, Lochocki N, et al
   Prostate MRI in Patients With Incidental Prostate Cancer Diagnosed by Transurethral Resection of the Prostate: Addressing a Guideline Gap.
   AJR Am J Roentgenol. 2026 Aug 19. doi: 10.2214/AJR.26.35470.
   PubMed    
   
   
   
2. PONSIGLIONE A, Brembilla G
   MRI Standards for Prostate Cancer Screening in the PRISM Consensus Recommendations.
   AJR Am J Roentgenol. 2026 Aug 5. doi: 10.2214/AJR.26.35683.
   PubMed    
   
   
   July 2026
3. SHETTY AS
   The Complementary Value of Prostate Bed MRI After a Negative PSMA PET/CT Examination in Prostate Cancer Biochemical Recurrence.
   AJR Am J Roentgenol. 2026 Jul 22. doi: 10.2214/AJR.26.35584.
   PubMed    
   
   
   
4. CHOI WP, Almaguel FG, Franquet-Elia E, Ghai S, et al
   Optimal Imaging Strategies After Negative PSMA PET/CT Results in Patients With Prostate Cancer Biochemical Recurrence: AJR Expert Panel Narrative Review.
   AJR Am J Roentgenol. 2026 Jul 15. doi: 10.2214/AJR.26.35081.
   PubMed     Abstract available
   
   
   June 2026
5. PEACOCK JG, Franquet-Elia E, Harris AL, Weeks JG, et al
   A Practical Guide to PSMA PET Radiopharmaceuticals for Prostate Cancer Imaging, From the AJR Special Series on Molecular Imaging.
   AJR Am J Roentgenol. 2026 Jun 24. doi: 10.2214/AJR.26.34730.
   PubMed     Abstract available
   
   
   
6. SARI ZNA, Bezuidenhout AF, Delgado N, Sari L, et al
   Prostate Feeding Artery on MRI: Association With Clinically Significant Prostate Cancer.
   AJR Am J Roentgenol. 2026 Jun 17. doi: 10.2214/AJR.26.35035.
   PubMed    
   
   
   May 2026
7. COSTA DN, Gupta AC, Shah RB, Cheney SM, et al
   Anatomy of the Prostate and Periprostatic Region: A Contemporary Review, From the AJR Special Series on Critical Anatomy.
   AJR Am J Roentgenol. 2026;226:e2533454.
   PubMed     Abstract available
   
   
   March 2026
8. LEE MH, Pickhardt PJ
   Advancing Clinically Feasible Opportunistic Screening: Use of Attenuation Correction CT From PET/CT for Osteoporosis and Fracture Risk Assessment in Patients With Prostate Cancer.
   AJR Am J Roentgenol. 2026 Mar 18. doi: 10.2214/AJR.26.34830.
   PubMed    
   
   
   December 2025
9. COSTA DN
   Toward Consistent and Actionable MRI Reporting for Prostate Cancer Staging.
   AJR Am J Roentgenol. 2025 Dec 24. doi: 10.2214/AJR.25.34410.
   PubMed    
   
   
   
10. PONSIGLIONE A
    Closing the Gap: Standardizing MRI for Prostate Cancer Local Staging.
    AJR Am J Roentgenol. 2025 Dec 17. doi: 10.2214/AJR.25.34406.
    PubMed    
    
    
    
11. ABREU-GOMEZ J, Eberhardt SC, Chapin BF, Fennessy FM, et al
    MRI for Prostate Cancer Local Staging: AJR Expert Panel Narrative Review.
    AJR Am J Roentgenol. 2025 Dec 10. doi: 10.2214/AJR.25.33846.
    PubMed     Abstract available
    
    
    November 2025
12. KRISHNA S, Bhayana R
    Biparametric MRI: Toward a Faster, Cheaper, Contrast-Media-Free Standard for Prostate Cancer Diagnosis.
    AJR Am J Roentgenol. 2025 Nov 5. doi: 10.2214/AJR.25.34135.
    PubMed    
    
    
    October 2025
13. NEDELCU A, Oerther B, Benkendorff A, Dieckbreder S, et al
    PI-RADS Version 2.1 for Prostate MRI Interpretation: Associations of Study Quality and Cancer Detection Metrics-A Systematic Review and Meta-Analysis.
    AJR Am J Roentgenol. 2025 Oct 15. doi: 10.2214/AJR.25.33583.
    PubMed     Abstract available
    
    
    August 2025
14. ABREU-GOMEZ J
    Artificial Intelligence-Assisted MRI Interpretation in Prostate Cancer: Supporting Confidence and Reducing Variability.
    AJR Am J Roentgenol. 2025 Aug 6. doi: 10.2214/AJR.25.33622.
    PubMed    
    
    
    July 2025
15. GELIKMAN DG, Yilmaz EC, Harmon SA, Huang EP, et al
    Evaluating Artificial Intelligence-Assisted Prostate Biparametric MRI Interpretation: An International Multireader Study.
    AJR Am J Roentgenol. 2025 Jul 16. doi: 10.2214/AJR.24.32399.
    PubMed     Abstract available
    
    
    
16. TIRUMANI SH
    Beyond the AJR: MRI-Directed Pathway Is the Preferred Strategy for the Workup of Suspected Prostate Cancer.
    AJR Am J Roentgenol. 2025 Jul 2. doi: 10.2214/AJR.25.33434.
    PubMed    
    
    
    March 2025
17. SPILSETH B
    Moving Towards Widespread Adoption of Prostate Cancer Screening With MRI: Questions Remaining for Optimization.
    AJR Am J Roentgenol. 2025 Mar 12. doi: 10.2214/AJR.25.32892.
    PubMed    
    
    
    
18. SALINAS-MIRANDA E, Birosh A, Mcinnes MDF, Breau RH, et al
    NPV of Biparametric and Multiparametric Prostate MRI: A Comparative Systematic Review and Meta-Analysis.
    AJR Am J Roentgenol. 2025 Mar 5. doi: 10.2214/AJR.24.32328.
    PubMed     Abstract available
    
    
    February 2025
19. SCHOOTS IG, Haider MA, Punwani S, Padhani AR, et al
    MRI in Prostate Cancer Screening: A Review and Recommendations, From the AJR Special Series on Screening.
    AJR Am J Roentgenol. 2025 Feb 19. doi: 10.2214/AJR.24.32588.
    PubMed     Abstract available
    
    
    December 2024
20. LEWIS S, Rastinehad AR
    Beyond the AJR: Prostate Cancer Screening-Safe Omission of Biopsy in Patients With Negative MRI and the Need for High-Quality Imaging Standards.
    AJR Am J Roentgenol. 2024 Dec 11. doi: 10.2214/AJR.24.32431.
    PubMed    
    
    
    October 2024
21. MARGOLIS DJA, Chatterjee A, deSouza NM, Fedorov A, et al
    Quantitative Prostate MRI, From the AJR Special Series on Quantitative Imaging.
    AJR Am J Roentgenol. 2024 Oct 2. doi: 10.2214/AJR.24.31715.
    PubMed     Abstract available
    
    
    May 2024
22. SAVIR-BARUCH B, Parent E
    Beyond the AJR: PET/MRI Using (68)Ga-RM2 Has Superior Performance to MRI Alone in the Localization of Lesions in Patients With Biochemical Failure After Prostate Cancer Treatment.
    AJR Am J Roentgenol. 2024 May 15. doi: 10.2214/AJR.24.31412.
    PubMed    
    
    
    April 2024
23. DIAS AB, Chang SD, Fennessy FM, Ghafoor S, et al
    New Prostate MRI Scoring Systems (PI-QUAL, PRECISE, PI-RR, and PI-FAB): AJR Expert Panel Narrative Review.
    AJR Am J Roentgenol. 2024 Apr 3. doi: 10.2214/AJR.24.30956.
    PubMed     Abstract available
    
    
    March 2024
24. DE OLIVEIRA CORREIA ET, Purysko AS, Paranhos BM, Shoag JE, et al
    Reply to "Prostate Cancer Screening and Prostate MRI: Hypotheses Founded on Uncertain Evidence".
    AJR Am J Roentgenol. 2024 Mar 20. doi: 10.2214/AJR.24.31168.
    PubMed    
    
    
    
25. TAKAHASHI T
    Prostate Cancer Screening and Prostate MRI: Hypotheses Founded on Uncertain Evidence.
    AJR Am J Roentgenol. 2024 Mar 20. doi: 10.2214/AJR.24.31070.
    PubMed    
    
    
    
26. DE OLIVEIRA CORREIA ET, Purysko AS, Paranhos BM, Shoag JE, et al
    Reply to "Is PI-RADS Ready for Biparametric Prostate MRI?".
    AJR Am J Roentgenol. 2024 Mar 20. doi: 10.2214/AJR.24.31169.
    PubMed    
    
    
    
27. DANA J, Reinhold C, Gauvin S
    Is PI-RADS Ready for Biparametric Prostate MRI?
    AJR Am J Roentgenol. 2024 Mar 20. doi: 10.2214/AJR.24.31094.
    PubMed    
    
    
    February 2024
28. DE OLIVEIRA CORREIA ET, Purysko AS, Paranhos BM, Shoag JE, et al
    PI-RADS Upgrading Rules: Impact on Prostate Cancer Detection and Biopsy Avoidance of MRI-Directed Diagnostic Pathways.
    AJR Am J Roentgenol. 2024 Feb 14. doi: 10.2214/AJR.23.30611.
    PubMed     Abstract available
    
    
    January 2024
29. LAWRENCE EM
    Editorial Comment: Similar Upgrade and Downgrade Rates Between PI-RADS Version 2.0 and Version 2.1.
    AJR Am J Roentgenol. 2024;222:e2330325.
    PubMed    
    
    
    December 2023
30. BIROSH A, Miranda ES, Breau RH, McInnes MDF, et al
    Multiparametric Versus Biparametric Prostate MRI: Comparison of NPV for Clinically Significant Prostate Cancer.
    AJR Am J Roentgenol. 2023 Dec 13. doi: 10.2214/AJR.23.30496.
    PubMed    
    
    
    November 2023
31. SANMUGALINGAM N, Sushentsev N, Lee KL, Caglic I, et al
    The PRECISE Recommendations for Prostate MRI in Patients on Active Surveillance for Prostate Cancer: A Critical Review.
    AJR Am J Roentgenol. 2023;221:649-660.
    PubMed     Abstract available
    
    
    October 2023
32. THAMPY R, Spilseth B
    Beyond the AJR: Increased Use of Prostate MRI Before Biopsy Reduces Biopsy Frequency Without Compromising Detection of Aggressive Cancer.
    AJR Am J Roentgenol. 2023 Oct 25. doi: 10.2214/AJR.23.30407.
    PubMed    
    
    
    
33. TAN N, Pollock JR, Margolis DJA, Padhani AR, et al
    Management of Patients With a Negative Multiparametric Prostate MRI Examination: AJR Expert Panel Narrative Review.
    AJR Am J Roentgenol. 2023 Oct 25. doi: 10.2214/AJR.23.29969.
    PubMed     Abstract available
    
    
    September 2023
34. YILMAZ EC, Lin Y, Belue MJ, Harmon SA, et al
    PI-RADS Version 2.0 Versus Version 2.1: Comparison of Prostate Cancer Gleason Grade Upgrade and Downgrade Rates From MRI-Targeted Biopsy to Radical Prostatectomy.
    AJR Am J Roentgenol. 2023 Sep 20. doi: 10.2214/AJR.23.29964.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum